The effect of long term ventilatory support on hemodynamics in children with spinal muscle atrophy (SMA) type II

Agneta Markström1, Gary Cohen, Miriam Katz-Salamon

  • 1Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, National Respiratory Centre, Stockholm, Sweden. agnetamarkstrom@hotmail.com

Sleep Medicine
|January 13, 2010
PubMed

Insights

Bi-level Positive Airway Pressure (Bi-PAP) therapy in children with Spinal Muscular Atrophy (SMA) does not negatively impact heart rate or blood pressure when optimized. Proper mask fit is crucial for stable hemodynamics during Bi-PAP treatment.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Cardiovascular Physiology

Background:

  • Bi-level Positive Airway Pressure (Bi-PAP) improves respiratory function in children with Spinal Muscular Atrophy (SMA) type II.
  • The impact of Bi-PAP on hemodynamic parameters like heart rate (HR) and blood pressure in these children remains largely unknown.
  • This study investigates the association between Bi-PAP during sleep and hemodynamic changes in children with SMA.

Purpose of the Study:

  • To determine if Bi-PAP therapy affects heart rate and blood pressure in children with SMA during sleep.
  • To assess the influence of optimal versus sub-optimal Bi-PAP settings on hemodynamic stability.
  • To evaluate the relationship between breathing efficiency and hemodynamic parameters under Bi-PAP support.

Main Methods:

  • Ten children (8-12 years) with SMA on long-term Bi-PAP underwent overnight polysomnography.
  • Heart rate (HR), electrocardiogram (ECG), respiratory movements, and blood gases were continuously monitored.
  • Blood pressure was estimated via pulse transit time (PTT); breathing efficiency was assessed using the phase angle between chest and abdominal movements.

Main Results:

  • Heart rate and pulse transit time during unsupported and optimal Bi-PAP breathing were comparable.
  • Blood gas levels (SaO2, TcO2, TcCO2) remained stable across breathing conditions.
  • Optimal Bi-PAP significantly improved breathing efficiency (phase angle decreased from 42 to 22 degrees).
  • Sub-optimal Bi-PAP with mask leakage led to increased variability in HR, PTT, and breathing effort.

Conclusions:

  • Optimized Bi-PAP therapy is hemodynamically safe for children with SMA.
  • Correct mask application and sealed fit are essential for maintaining stable hemodynamics.
  • Bi-PAP effectively enhances respiratory efficiency without adverse cardiovascular effects in pediatric SMA patients when properly managed.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: